356 REFERENCES 1 Kellokumpu-Lehtonen P, Santti R, Pelliniemi LJ. Correlation of early cytodifferentiation of the human fetal prostate and Leydig cells. Anat Rec 1980;196:263–273. 2 Hayward SW, Cunha GR. The prostate: development and physiology. Radiol Clin North Am 2000;38:1–14. 3 Hayward SW, Baskin LS, Haughney PC et al. Epithelial development in the rat ventral prostate, anterior prostate and seminal vesicle. Acta Anat 1996;155:81–93. 4 Hayward SW, Baskin LS, Haughney PC et al. Stromal development in the ventral prostate, anterior prostate and seminal vesicle of the rat. Acta Anat 1996;155:94–103. 5 Wang Y, Hayward S, Cao M et al. Cell differentiation lineage in the prostate. Differentiation 2001;68:270–279. 6 Gleason DF. Histologic grading and clinical staging of prostatic carci- noma. In: Tannenbaum M, ed., Urologic Pathology: Lea and Febiger; 1977:171–198. 7 Cunha GR. Tissue interactions between epithelium and mesenchyme of urogenital and integumental origin. Anat Rec 1972;172:529–542. 8 Cunha GR. Epithelio-mesenchymal interactions in primordial gland structures which become responsive to androgenic stimulation. Anat Rec 1972;172:179–196. 9 Hayward SW, Haughney PC, Rosen MA et al. Interactions between adult human prostatic epithelium and rat urogenital sinus mesenchyme in a tissue recombination model. Differentiation 1998;63:131–140. 10 Shappell SB, Boeglin WE, Olson SJ et al. 15-Lipoxygenase-2 (15- LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma. Am J Pathol 1999;155:235–245. 11 Matuo Y, Adams PS, Nishi N et al. The androgen-dependent rat prostate protein, probasin, is a heparin-binding protein that co-puriﬁes with hepa- rin-binding growth factor-1. In Vitro Cell Dev Biol 1989;25:581–584. 12 Li H, Jiang M, Honorio S et al. Methodologies in assaying prostate cancer stem cells. Methods Mol Biol 2009;568:85–138. 13 Isaacs JT. Control of cell proliferation and death in the normal and neoplastic prostate: a stem cell model. In: Rogers CH, Coffey DS, Cunha GR, Grayhack JT, Hinman Jr F, Horton R, eds. Benign Pros- tatic Hyperplasia. Bethesda: National Institutes of Health; 1985:85–94. 14 Tsujimura A, Koikawa Y, Salm S et al. Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J Cell Biol 2002;157:1257–1265. 15 Hayward SW, Dahiya R, Cunha GR et al. Establishment and charac- terization of an immortalized but non-tumorigenic human prostate epi- thelial cell line: BPH-1. In Vitro Cell Dev Biol Anim 1995;31:14–24. 16 Bello D, Webber MM, Kleinman HK et al. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillo- mavirus 18. Carcinogenesis 1997;18:1215–1223. 17 Hayward SW, Wang Y, Cao M et al. Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res 2001; 61:8135–8142. 18 Roh M, Franco OE, Hayward SW et al. A role for polyploidy in the tumorigenicity of Pim-1-expressing human prostate and mammary epi- thelial cells. PLoS One 2008;3:e2572. 19 Bhatia B, Jiang M, Suraneni M et al. Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells. J Biol Chem 2008;283: 27957–27972. 20 Hayward S, Cox S, Mitchell I et al. The effects of interferons on the activity of a-glycerolphosphate dehydrogenase in benign prostatic hyperplasia cells in primary culture. J Urol 1987;138:648–653. 21 Hallowes RC, Cox S, Hayward S et al. Effects of ﬂutamide and hydroxy-ﬂutamide on the growth of human benign prostatic hyperpla- sia cells in primary culture: A preliminary report. Anticancer Res 1991;11:1799–1806. 22 Tang DG, Tokumoto YM, Apperly JA et al. Lack of replicative senescence in cultured rat oligodendrocyte precursor cells. Science 2001;291:868–871. 23 Staack A, Donjacour AA, Brody J et al. Mouse urogenital develop- ment: a practical approach. Differentiation 2003;71:402–413. Remodeling of Prostatic Tissue by Progenitor Cell 24 Hayward SW, Haughney PC, Lopes ES et al. The rat prostatic epithe- lial cell line NRP-152 can differentiate in vivo in response to its stro- mal environment. Prostate 1999;39:205–212. 25 Aguirre AJ, Brennan C, Bailey G et al. High-resolution characteriza- tion of the pancreatic adenocarcinoma genome. Proc Natl Acad Sci USA 2004;101:9067–9072. 26 Protopopov A, Feng B, Chin L. Full complexity genomic hybridiza- tion on 60-mer oligonucleotide microarrays for array comparative genomic hybridization (aCGH). Methods Mol Biol 2008;439:87–100. 27 Yi Y, Mirosevich J, Shyr Y et al. Coupled analysis of gene expression and chromosomal location. Genomics 2005;85:401–412. 28 Brown MD, Gilmore PE, Hart CA et al. Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations. Prostate 2007;67:1384–1396. 29 Korsten H, Ziel-van der Made A, Ma X et al. Accumulating progeni- tor cells in the luminal epithelial cell layer are candidate tumor initiat- ing cells in a Pten knockout mouse prostate cancer model. PLoS One 2009;4:e5662. 30 Yamada KM, Cukierman E. Modeling tissue morphogenesis and can- cer in 3D. Cell 2007;130:601–610. 31 Lee GY, Kenny PA, Lee EH et al. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 2007;4: 359–365. 32 Wieser M, Stadler G, Jennings P et al. hTERT alone immortalizes epi- thelial cells of renal proximal tubules without changing their func- tional characteristics. Am J Physiol Renal Physiol 2008;295: F1365–F1375. 33 Gudjonsson T, Villadsen R, Ronnov-Jessen L et al. Immortalization protocols used in cell culture models of human breast morphogenesis. Cell Mol Life Sci 2004;61:2523–2534. 34 Thomson AA, Cunha GR. Prostatic growth and development are regu- lated by FGF10. Development 1999;126:3693–3701. 35 Donjacour AA, Thomson AA, Cunha GR. FGF-10 plays an essential role in the growth of the fetal prostate. Dev Biol 2003;261:39–54. 36 Vanpoucke G, Orr B, Grace OC et al. Transcriptional proﬁling of in- ductive mesenchyme to identify molecules involved in prostate devel- opment and disease. Genome Biol 2007;8:R213. 37 Gao N, Ishii K, Mirosevich J et al. Forkhead box A1 regulates pros- tate ductal morphogenesis and promotes epithelial cell maturation. De- velopment 2005;132:3431–3443. 38 Bieberich CJ, Fujita K, He WW et al. Prostate-speciﬁc and androgen- dependent expression of a novel homeobox gene. J Biol Chem 1996; 271:31779–31782. 39 Sciavolino PJ, Abrams EW, Yang L et al. Tissue-speciﬁc expression of murine Nkx3.1 in the male urogenital system. Dev Dyn 1997;209: 127–138. 40 Podlasek CA, Clemens JQ, Bushman W. Hoxa-13 gene mutation results in abnormal seminal vesicle and prostate development. J Urol 1999;161:1655–1661. 41 Podlasek CA, Seo RM, Clemens JQ et al. Hoxa-10 deﬁcient male mice exhibit abnormal development of the accessory sex organs. Dev Dyn 1999;214:1–12. 42 Lamm ML, Catbagan WS, Laciak RJ et al. Sonic hedgehog activates mesenchymal Gli1 expression during prostate ductal bud formation. Dev Biol 2002;249:349–366. 43 Isaacs JT, Coffey DS. Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl 1989;2:33–50. 44 Gu G, Yuan J, Wills M et al. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res 2007;67:4807–4815. 45 Xin L, Lawson DA, Witte ON. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci USA 2005;102:6942–6947. 46 Tokar EJ, Ancrile BB, Cunha GR et al. Stem/progenitor and interme- diate cell types and the origin of human prostate cancer. Differentia- tion; Research In Biological Diversity 2005;73:463–473. 47 Uzgare AR, Xu Y, Isaacs JT. In vitro culturing and characteristics of transit amplifying epithelial cells from human prostate tissue. J Cell Biochem 2004;91:196–205. See www.StemCells.com for supporting information available online.